CONTEXT: International guidelines recommend the routine use of oxygen therapy in the treatment of myocardial infarction (MI). OBJECTIVE: To undertake a systematic review and meta-analysis of randomised placebo-controlled trials of oxygen therapy in MI. DATA SOURCES: Medline, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, EMBASE and CINHAL. STUDY SELECTION: Randomised placebo-controlled trials of oxygen therapy in MI. DATA EXTRACTION: The primary clinical outcome was mortality. RESULTS: Two of 51 potential studies met the inclusion criteria. The one study with substantive clinical outcome data reported that in uncomplicated MI, high-flow oxygen was associated with a non-significant increased risk of death (risk ratio 2.9, 95% CI 0.8 to 10.3, p = 0.08) and a greater serum aspartate aminotransferase level (difference 19.2 IU/ml, 95% CI 0 to 38.4, p = 0.05) than room air. CONCLUSION: The limited evidence that does exist suggests that the routine use of high-flow oxygen in uncomplicated MI may result in a greater infarct size and possibly increase the risk of mortality.
No takes yet. Share an insight, caveat, or question.
Wijesinghe et al. (2008) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: